title: Principal component analysis uncovers cytomegalovirus-associated NK cell activation in Ph+leukemia patients treated with dasatinib.
authors.forename: K
authors.initials: K
authors.lastname: Ishiyama
authors.forename: T
authors.initials: T
authors.lastname: Kitawaki
authors.forename: N
authors.initials: N
authors.lastname: Sugimoto
authors.forename: T
authors.initials: T
authors.lastname: Sozu
authors.forename: N
authors.initials: N
authors.lastname: Anzai
authors.forename: M
authors.initials: M
authors.lastname: Okada
authors.forename: M
authors.initials: M
authors.lastname: Nohgawa
authors.forename: K
authors.initials: K
authors.lastname: Hatanaka
authors.forename: N
authors.initials: N
authors.lastname: Arima
authors.forename: T
authors.initials: T
authors.lastname: Ishikawa
authors.forename: S
authors.initials: S
authors.lastname: Tabata
authors.forename: T
authors.initials: T
authors.lastname: Onaka
authors.forename: S
authors.initials: S
authors.lastname: Oka
authors.forename: Y
authors.initials: Y
authors.lastname: Nakabo
authors.forename: R
authors.initials: R
authors.lastname: Amakawa
authors.forename: M
authors.initials: M
authors.lastname: Matsui
authors.forename: T
authors.initials: T
authors.lastname: Moriguchi
authors.forename: A
authors.initials: A
authors.lastname: Takaori-Kondo
authors.forename: N
authors.initials: N
authors.lastname: Kadowaki